GO:1900136 regulation of chemokine activity: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900136 regulation of chemokine activity describes any process that modulates the frequency, rate or extent of chemokine activity, a critical control point in inflammation and immunity.
• Chemokine activity is regulated at multiple levels, including post-translational modification, proteolytic processing, glycosylation, and transcriptional control [1,4,6].
• Key regulatory mechanisms include N-terminal truncation by proteases, citrullination, and glycosylation, which can either enhance or abolish chemokine function [1,4].
• Regulators of G-protein signaling (RGS) proteins fine-tune chemokine-induced lymphocyte migration by accelerating GTP hydrolysis on G-alpha subunits.
• Dysregulation of chemokine activity is implicated in inflammatory diseases, cancer, and angiogenesis, making it a therapeutic target [2,7,8].
• CRISPR-based models (knockout, knock-in, point mutation, overexpression) enable causal dissection of genes controlling chemokine activity.
Description
Chemokines are a family of small cytokines that direct the migration of leukocytes and play central roles in inflammation, immunity, and development. Their activity is not static; it is dynamically regulated to ensure appropriate spatial and temporal responses. The Gene Ontology term GO:1900136, regulation of chemokine activity, captures any process that modulates the frequency, rate or extent of chemokine activity. This regulation is essential for mounting effective immune responses while preventing excessive tissue damage. Researchers study this term to understand how chemokine gradients are established, maintained, and terminated, and how dysregulation contributes to disease [1,5]. The regulation occurs at multiple levels, including post-translational modifications such as proteolytic cleavage, citrullination, and glycosylation, as well as transcriptional control of chemokine genes [1,4,6]. For example, in vivo regulation by post-translational modification can convert chemokines into antagonists or enhance their potency. Interleukin-8 (CXCL8), a prototypical chemokine, exemplifies how activity is fine-tuned through processing and receptor interactions. Understanding these mechanisms is critical for developing therapies that target chemokine-driven pathologies, including chronic inflammation, cancer, and angiogenesis [7,8].
regulation of chemokine activity At A Glance
| GO ID | GO:1900136 |
|---|---|
| GO term | regulation of chemokine activity |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate or extent of chemokine activity |
| Regulatory mechanisms | Post-translational modification, proteolysis, glycosylation, transcriptional control |
| Key regulators | Proteases (e.g., MMPs, DPP4), RGS proteins, glycosyltransferases |
| Associated diseases | Inflammation, cancer, angiogenesis, autoimmune disorders |
What Is GO:1900136?
GO:1900136 regulation of chemokine activity is defined as any process that modulates the frequency, rate or extent of chemokine activity. In other words, it encompasses all biological mechanisms that control how strongly, how long, and where chemokines function. This includes modifications that activate or inactivate chemokines, changes in their expression levels, and interactions with binding partners or receptors that alter their signaling capacity.
Why Is regulation of chemokine activity Important in Cell Biology?
Regulation of chemokine activity is fundamental to immune surveillance and tissue homeostasis. It ensures that leukocytes migrate to the right place at the right time, and its dysregulation can lead to chronic inflammation, impaired pathogen clearance, or tumor progression [5,7]. Because chemokines are involved in numerous diseases, understanding their regulation offers opportunities for therapeutic intervention [2,8].
• Controls leukocyte trafficking and positioning in lymphoid organs and peripheral tissues.
• Modulates inflammatory responses to infection and injury.
• Regulates angiogenesis and tumor microenvironment interactions.
• Influences cancer metastasis by directing chemokine gradients.
• Affects autoimmune diseases such as rheumatoid arthritis and multiple sclerosis.
• Determines the efficacy of chemokine-based immunotherapies.
• Provides targets for anti-inflammatory drug development.
• Shapes lymphocyte development and migration through RGS proteins.
• Impacts wound healing and tissue repair.
• Plays a role in neuroinflammation and neurodegeneration.
What Happens During regulation of chemokine activity?
Post-translational modifications
In simple terms: Chemokines can be chemically altered after they are made, which changes how well they work.
Post-translational modifications (PTMs) are a major mechanism for regulating chemokine activity. These include proteolytic cleavage, citrullination, nitration, and glycosylation. For example, in vivo regulation by PTMs can generate chemokine variants with altered receptor binding and signaling properties. N-terminal truncation by proteases such as matrix metalloproteinases (MMPs) or dipeptidyl peptidase 4 (DPP4) can convert chemokines into antagonists or superagonists, thereby fine-tuning immune cell recruitment [1,5].
Proteolytic processing and N-terminal truncation
In simple terms: Enzymes can cut off a small piece of the chemokine, which can turn it on, off, or change its target.
Proteolytic processing of the chemokine N-terminus is a key regulatory step. Many chemokines are secreted as precursors that require cleavage to become active, while others are inactivated by truncation. For instance, CCL14 is activated by N-terminal proteolysis, and this process is regulated by glycosylation. The balance between activating and inactivating proteases determines the local chemokine activity landscape.
Glycosylation
In simple terms: Sugar molecules attached to chemokines can protect them from being cut or change how they signal.
Glycosylation is a common post-translational modification that regulates chemokine activity. It can protect chemokines from proteolytic degradation, modulate receptor binding, and influence their bioavailability. A study on CCL14 demonstrated that glycosylation regulates its N-terminal proteolysis and activity, highlighting the interplay between glycosylation and proteolysis in controlling chemokine function. This adds another layer of complexity to the regulation of chemokine activity.
Transcriptional regulation
In simple terms: Cells can control how much chemokine they produce by turning the gene on or off.
Transcriptional regulation of chemokine genes is a fundamental mechanism controlling chemokine availability. For example, the transcription factor RelB regulates chemokine expression to modulate local inflammation. Similarly, fine-tuning of CXCL1 transcription involves multiple regulatory elements and transcription factors. These transcriptional controls ensure that chemokines are produced in appropriate amounts and at the right time during immune responses.
Regulation by RGS proteins
In simple terms: RGS proteins act like brakes on chemokine signaling, preventing overreaction.
Regulators of G-protein signaling (RGS) proteins modulate chemokine-induced lymphocyte migration by accelerating the intrinsic GTPase activity of G-alpha subunits, thereby terminating signals from chemokine receptors. This regulation is crucial for maintaining directed cell migration and preventing excessive or misdirected immune responses. RGS proteins thus represent an important intracellular checkpoint in the regulation of chemokine activity [3,5].
Key Genes Involved in GO:1900136 regulation of chemokine activity
The following genes and proteins are key players in the regulation of chemokine activity, encompassing proteases, glycosyltransferases, transcription factors, and signaling modulators.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CXCL8 | Prototypical chemokine; regulates neutrophil recruitment | Model for chemokine processing and receptor binding |
| CCL14 | Chemokine activated by N-terminal proteolysis; glycosylation regulates activity | Studying PTM crosstalk in chemokine regulation |
| MMP9 | Matrix metalloproteinase; cleaves chemokines to modulate activity | Investigating proteolytic regulation of chemokine gradients |
| DPP4 | Dipeptidyl peptidase 4; truncates chemokines altering receptor specificity | Target for diabetes and inflammation research |
| RGS1 | Regulator of G-protein signaling; modulates chemokine receptor signaling | Lymphocyte migration studies |
| RGS2 | Regulator of G-protein signaling; attenuates chemokine-induced responses | Immune cell trafficking research |
| RELB | Transcription factor; regulates chemokine expression | Inflammation models |
| NFKB1 | Transcription factor; controls chemokine gene transcription | Inflammatory signaling studies |
| CXCL1 | Chemokine involved in neutrophil recruitment; transcriptionally regulated | Cancer and inflammation research |
| CXCL12 | Chemokine regulating stem cell homing and metastasis | Angiogenesis and cancer models |
| CCL2 | Chemokine recruiting monocytes; regulated by proteolysis | Atherosclerosis and neuroinflammation |
| CXCL10 | Chemokine involved in Th1 responses; regulated by PTMs | Autoimmune disease models |
| CCL5 | Chemokine stored in platelets; regulated by proteolysis | Inflammation and HIV research |
| IL8 | Alternative symbol for CXCL8 | See CXCL8 |
| ACKR1 | Atypical chemokine receptor; regulates chemokine availability | Chemokine scavenging studies |
| ACKR2 | Atypical chemokine receptor; modulates chemokine gradients | Inflammation resolution |
| ACKR3 | Atypical chemokine receptor; regulates CXCL12 activity | Cancer and development |
How Is regulation of chemokine activity Regulated?
The regulation of chemokine activity is itself subject to higher-order control. Transcriptional regulators such as NF-kB and RelB control chemokine gene expression in response to inflammatory stimuli [6,7]. Post-transcriptional mechanisms, including mRNA stability and microRNAs, further modulate chemokine levels. At the protein level, proteases and glycosyltransferases act in concert to determine the final activity of secreted chemokines [1,4]. Additionally, RGS proteins provide intracellular feedback that desensitizes chemokine receptor signaling, preventing excessive responses. This multilayered regulation ensures that chemokine activity is tightly coupled to the physiological context.
regulation of chemokine activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CXCL8 | Inflammation, cancer | Knockout mice, overexpression cell lines |
| CCL14 | Inflammation, cancer | Point mutation to prevent glycosylation |
| RELB | Chronic inflammation | Knockout mice |
| CXCL12 | Cancer metastasis, angiogenesis | Knock-in reporter mice |
| RGS1 | Autoimmune diseases | Knockout T cells |
Inflammation and autoimmune diseases
Dysregulated chemokine activity is a hallmark of chronic inflammatory diseases. For example, RelB-mediated regulation of chemokine expression modulates local inflammation, and its dysregulation can lead to persistent tissue damage. In rheumatoid arthritis and multiple sclerosis, altered chemokine processing and glycosylation contribute to pathological leukocyte recruitment [1,5]. Targeting the enzymes that regulate chemokine activity, such as proteases and glycosyltransferases, is a promising therapeutic strategy.
Cancer and metastasis
Chemokines and their regulation play dual roles in cancer. They can promote anti-tumor immunity by recruiting effector T cells, but they can also support tumor growth, angiogenesis, and metastasis. For instance, CXCL8 (IL-8) is often overexpressed in tumors and its activity is regulated by proteolytic processing, influencing neutrophil infiltration and tumor progression. The regulation of chemokine activity thus represents a critical node in the tumor microenvironment.
Angiogenesis and vascular biology
Chemokines such as CXCL12 and CXCL8 regulate angiogenesis by recruiting endothelial progenitor cells and promoting vessel formation. The activity of these chemokines is controlled by post-translational modifications and interactions with atypical chemokine receptors, which fine-tune their angiogenic potential. Dysregulation can lead to aberrant angiogenesis in tumors and ischemic diseases.
From regulation of chemokine activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does protease X regulate chemokine activity in vivo? | Knockout mouse for protease X |
| How does glycosylation affect CCL14 activity? | Point mutation at glycosylation site |
| Can a chemokine variant resist proteolysis? | Knock-in of mutated chemokine |
| Where is a chemokine expressed during inflammation? | Tagged knock-in reporter |
| Does overexpression of RGS protein reduce chemokine signaling? | Overexpression cell line |
| What is the role of RelB in chemokine transcription? | Knockout and rescue models |
How to Study the regulation of chemokine activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry | Chemokine modifications and cleavage | Identifying PTMs |
| RNA-seq | Chemokine gene expression | Transcriptional regulation |
| ChIP-seq | Transcription factor binding | Regulatory elements |
| Transwell migration | Cell migration in response to chemokines | Functional activity |
| CRISPR screen | Genes affecting chemokine activity | Discovery of regulators |
| ELISA | Chemokine protein levels | Quantification in samples |
| Flow cytometry | Receptor expression and signaling | Immune cell analysis |
Proteomics and PTM analysis
Mass spectrometry-based proteomics is essential for identifying post-translational modifications on chemokines, such as cleavage sites, glycosylation, and citrullination. These methods reveal how chemokine activity is regulated at the protein level [1,4].
Transcriptional profiling
RNA-seq and ChIP-seq can map the transcriptional regulation of chemokine genes, identifying transcription factors and regulatory elements that control chemokine expression [6,7].
Chemotaxis assays
In vitro chemotaxis assays using transwell systems or microfluidic devices measure the functional impact of chemokine regulation on cell migration. These are often combined with genetic perturbations [3,5].
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate chemokine activity, such as proteases, glycosyltransferases, and signaling modulators.
How CRISPR Can Be Used to Study GO:1900136 regulation of chemokine activity
Knockout
CRISPR knockout of candidate regulators (e.g., proteases, RGS proteins) allows researchers to assess their necessity for chemokine activity in cellular and animal models. For example, knocking out MMP9 can reveal its role in chemokine processing.
Point Mutation
Introducing point mutations at specific residues (e.g., glycosylation sites or cleavage sites) in chemokine genes can dissect the contribution of individual modifications to activity. This is exemplified by studies on CCL14 glycosylation.
Knock-in
Knock-in of tagged or mutant chemokines enables tracking of expression, localization, and processing in vivo. This approach can reveal how regulatory elements control chemokine availability.
Overexpression
Overexpression of chemokines or their regulators (e.g., RGS proteins) can test sufficiency in driving or inhibiting chemokine responses. This is useful for validating gain-of-function mechanisms.
How EDITGENE Supports regulation of chemokine activity Research
Researchers studying regulation of chemokine activity-related genes often need to determine whether a candidate gene is causally involved in chemokine regulation or is merely correlated. EDITGENE provides a comprehensive suite of CRISPR services to enable such causal studies, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for regulation of chemokine activity research.
Frequently Asked Questions About regulation of chemokine activity
What is GO:1900136 regulation of chemokine activity?
GO:1900136 is a Gene Ontology term defined as any process that modulates the frequency, rate or extent of chemokine activity. It encompasses mechanisms such as post-translational modifications, proteolysis, and transcriptional control.
What genes are involved in regulation of chemokine activity?
Key genes include CXCL8, CCL14, MMP9, DPP4, RGS1, RGS2, RELB, NFKB1, CXCL1, CXCL12, CCL2, CXCL10, CCL5, ACKR1, ACKR2, and ACKR3, among others [1,2,3,4,5,6,7,8].
How is chemokine activity regulated?
Chemokine activity is regulated at multiple levels, including proteolytic cleavage, glycosylation, citrullination, transcriptional control, and intracellular signaling via RGS proteins [1,3,4,5].
What diseases are associated with dysregulated chemokine activity?
Dysregulated chemokine activity is linked to chronic inflammation, autoimmune diseases, cancer, metastasis, and aberrant angiogenesis [1,2,7,8].
What is the role of post-translational modification in chemokine activity?
Post-translational modifications such as proteolysis and glycosylation can activate, inactivate, or alter the receptor specificity of chemokines, thereby fine-tuning immune responses [1,4].
How do RGS proteins regulate chemokine activity?
RGS proteins accelerate GTP hydrolysis on G-alpha subunits, terminating chemokine receptor signaling and modulating lymphocyte migration.
Can CRISPR be used to study regulation of chemokine activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of genes regulating chemokine activity.
What methods are used to study chemokine regulation?
Common methods include mass spectrometry for PTMs, RNA-seq for transcription, chemotaxis assays for function, and CRISPR screens for discovery [1,3,5,6].
Why is regulation of chemokine activity important in cancer?
It influences immune cell infiltration, angiogenesis, and metastasis, making it a target for cancer immunotherapy [2,8].
What are atypical chemokine receptors?
Atypical chemokine receptors such as ACKR1, ACKR2, and ACKR3 regulate chemokine availability and gradients without triggering classical signaling.
Conclusion
Regulation of chemokine activity (GO:1900136) is a critical biological process that ensures precise control of immune cell trafficking and inflammation. It operates through diverse mechanisms including post-translational modifications, proteolysis, glycosylation, transcriptional regulation, and RGS-mediated signaling. Dysregulation contributes to a wide range of diseases, from chronic inflammation to cancer. Understanding these regulatory mechanisms offers promising avenues for therapeutic intervention. EDITGENE provides advanced CRISPR tools to study these processes and accelerate discovery.
References
- 1. Moelants EA et al.. 2013. In vivo regulation of chemokine activity by post-translational modification.. Immunol Cell Biol 91(6):402-7 PMID: 23628804
- 2. Matsushima K et al.. 2022. Interleukin-8: An evolving chemokine.. Cytokine 153:155828 PMID: 35247648
- 3. Moratz C et al.. 2004. Regulation of chemokine-induced lymphocyte migration by RGS proteins.. Methods Enzymol 389:15-32 PMID: 15313557
- 4. Wang S et al.. 2021. Glycosylation Regulates N-Terminal Proteolysis and Activity of the Chemokine CCL14.. ACS Chem Biol 16(6):973-981 PMID: 33988967
- 5. Mortier A et al.. 2012. Overview of the mechanisms regulating chemokine activity and availability.. Immunol Lett 145(1-2):2-9 PMID: 22698177
- 6. Amiri KI et al.. 2003. Fine tuning the transcriptional regulation of the CXCL1 chemokine.. Prog Nucleic Acid Res Mol Biol 74:1-36 PMID: 14510072
- 7. Xia Y et al.. 1997. RelB regulation of chemokine expression modulates local inflammation.. Am J Pathol 151(2):375-87 PMID: 9250151
- 8. Dimberg A. 2010. Chemokines in angiogenesis.. Curr Top Microbiol Immunol 341:59-80 PMID: 20373091
